427 studies found for:    Open Studies | "Tissue Donors"
Show Display Options
Rank Status Study
21 Recruiting Organ Donor Tissue Oxygen Saturation as a Predictor of Number of Organs to Transplant Per Donor
Condition: Brain Death
Intervention:
22 Recruiting Efficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing
Conditions: Late Complication From Skin Graft;   Infection of Skin Donor Site;   Impaired Wound Healing;   Pain, Intractable;   Transepidermal Water Loss (TEWL)
Interventions: Device: Silk fibroin with bioactive coating layer dressing;   Device: Bactigras wound dressing
23 Recruiting Donor Lymphocyte Infusion After Alternative Donor Transplantation
Condition: Immunocompromised After T-cell Depleted Transplant.
Intervention: Biological: Infusion of donor lymphocytes
24 Recruiting Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors
Condition: Acute Myeloid Leukemia
Interventions: Drug: Transplants from 8/8-matched Unrelated donors;   Drug: Transplants from family-mismatched/haploidentical donors
25 Recruiting Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor Stem Cell Infusion
Condition: Kidney Transplantation
Intervention: Biological: Kidney and hematopoietic stem cell transplant/novel platform technology
26 Recruiting Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross
Condition: Dengue
Intervention: Device: Procleix Dengue Virus Assay
27 Unknown  Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes
Condition: Renal Transplantation
Intervention: Drug: TAIZ
28 Recruiting Pressure Controlled Versus Volume Controlled Mechanical Ventilation During Anesthesia for Living Donor Liver Transplantation Recipients
Condition: Living Donor Liver Transplantation Recipients
Intervention: Device: mechanical ventilation
29 Recruiting Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome
Intervention: Biological: ATIR
30 Recruiting Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®
Conditions: Healthy Allogeneic Donors;   Granulocyte Colony-stimulating Factor (G-CSF) Mobilized
Interventions: Device: Spectra Optia® IDL-Set;   Device: Spectra Optia® Collection Set
31 Recruiting National Marrow Donor Program Long-Term Donor Follow-Up
Condition: Hematologic Neoplasms
Intervention:
32 Recruiting Selecting a Favorable KIR Donor in Unrelated HCT for AML
Condition: Acute Myelogenous Leukemia
Interventions: Biological: KIR genotype;   Biological: Unrelated donor transplant
33 Recruiting Transcystic Versus Transanastomotic Tube Drainage in Right Lobe LDLT
Condition: Living Donor Liver Transplantation
Intervention: Device: biliary drainage tube
34 Unknown  Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells
Conditions: Acute Myeloid Leukemias;   Advanced Hematological Malignancies;   Indication for Allogeneic Stem Cell Transplantation;   no HLA-identical Donor Available
Intervention: Biological: Haploidentical transplantation with donor NK cells
35 Recruiting Remote Ischemic Preconditioning in Neurological Death Organ Donors
Condition: Transplantation
Intervention: Other: RIPC (Remote Ischemic Preconditioning)
36 Unknown  Protective Ventilatory Strategy in Potential Organ Donors
Condition: Mechanical Ventilation
Intervention: Procedure: change ventilation
37 Recruiting Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoid Leukemia
Intervention: Procedure: alloHCT
38 Recruiting Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Condition: Leukemia
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: methotrexate;   Procedure: allogeneic hematopoietic stem cell transplantation
39 Unknown  A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs
Condition: Implantation, Embryo
Interventions: Drug: Leuprolide;   Drug: Ganirelix
40 Recruiting T-cell Depleted Alternative Donor Transplantation
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Lymphomas;   Bone Marrow Failure;   Hemoglobinopathy;   Immune Deficiency;   Osteopetrosis
Intervention: Device: CliniMACS® (T cell depletion)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years